Acne therapy in infancy and childhood

Dermatologic Therapy

Volumn 6, Issue , 1998, Pages 74-81

  Lucky, Anne W ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; ISOTRETINOIN; MINOCYCLINE; TETRACYCLINE;

ACNE; HUMAN; NEWBORN CARE; ONSET AGE; REVIEW; SKIN SCAR;

EID: 0031731972     PISSN: 13960296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Lucky AW. A review of infantile and pediatric acne. Dermatology 1998: 196: 95-97.
2. Jansen T, Burgdorf WHC, Plewig G. Pathogenesis and treatment of acne in childhood. Pediatr Dermatol 1997: 14: 17-21.
3. Janniger CK. Neonatal and infantile acne vulgaris. Cutis 1993: 52: 16.
4. Rapelanoro R, Mortureux P, Couprie B, Maleville J, Taieb A. Neonatal Malassezia furfur pustulosis. Arch Dermatol 1996: 132: 190-193.
5. MacFarlane JT, Davies D. Infantile acne associated with transient increases in plasma concentrations of luteinising hormone, follicle-stimulating hormone, and testosterone. BMJ 1981: 282: 1275-1276
6. Cove JH, Eady A, Cunliffe WJ. Skin carriage of AnTibiotic-resistant coagulase-negative staphylococci in untreated subjects. J Antimicrob Chemother 1990: 25: 459-469.
7. Harkaway KS, McGinley KM, Foglia AN, Lee WL, Fried F, Shalita AR, Leyden JJ. Antibiotic-resistance patterns in coagulase-negative staphylococci after treatment with topical erythromycin, benzoyl peroxide, and combination therapy. Br J Dermatol 1992: 126: 585-590.
8. Forssman T. Antibiotic resistance in acne patients under antibiotic treatment in comparison to an untreated control group with retrospective assessment of therapy. Curr Probl Dermatol 1995: 22: 91-97.
9. Physician's Desk Reference. Tetracycline. 1996: 1367.
10. Burket JM, Storrs FJ. Nodulocystic infantile acne occurring in a kindred of steatocystoma. Arch Dermatol 1987: 123: 432-433.
11. Arbegast KD, Braddock SW, Lamberty LF, Sawka AR. Treatment of infantile cystic acne with oral isotretinoin: a case report. Pediatr Dermatol 1991: 8: 166-168.
12. Horne HL, Carmichael AJ. Juvenile Nodulocystic acne responding to systemic isotretinoin. Br J Dermatol 1997: 136: 796-797.
13. McGuire J, Lawson JP. Skeletal changes associated with chronic isotretinoin and etretinate administration. Dermatologica 1987: 175: 169-181.
14. Carey BM, Parkin GJS, Cunliffe WJ, Pritlove J. Skeletal toxicity with isotretinoin therapy: a clinico-radiological evaluation. Br J Dermatol 1988: 119: 609-614.
15. Kocijancic M. 13-cis-Retinoic acid and bone densiity. Int J Dermatol 1995: 34: 733-734.
16. DiGiovanna JJ, Sollitto RB, Abagan DL, Steinberg SM, Reynolds JC. Osteoporosis is a toxic effect of long-term etretinate therapy. Arch Dermatol 1995: 131: 1263-1267.
17. Margolis DJ, Attie M, Leyden JJ. Effects of isotretinoin on bone mineralization during routine therapy with isotretinoin for acne vulgaris. Arch Dermatol 1996: 132: 769-774.
18. Chew EW, Bingham A, Burrows D. Incidence of acne vulgaris in patients with infantile acne. Clin Exp Dermatol 1990: 15: 376-377.
19. Lucky AW, Biro FM, Huster GA, Morrison JA, Elder N. Acne vulgaris in early adolescent boys. Arch Dermatol 1991: 127: 210-216.
20. Lucky AW, Biro FM, Huster GA, Leach AD, Morrison JA, Ratterman J. Acne vulgaris in premenarchal girls. Arch Dermatol 1994: 130: 308-314.
21. Lucky AW, Biro FM, Simbartl LA, Morrison JA, Sorg NW. Predictors of severity of acne vulgaris in young adolescent girls: results of a five-year longitudinal study. J Pediatr 1997: 130: 30-39.
22. Lucky AW, Henderson TA, Olson WH, Robisch DM, Lebwohl M, Swinyer LJ. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. J Am Acad Dermatol 1997: 37: 745-54.